These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36655131)

  • 1. Synthesis of Novel Kidney-Type Glutaminase Allosteric Inhibitors Targeting the Critical Lys-320 Residue.
    Song J; Pan C; Li J; Bai R; Zeng Z; Han Y; Chen Z; Hou W; Li Y; Ruan BH
    ACS Med Chem Lett; 2023 Jan; 14(1):11-17. PubMed ID: 36655131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diselenide Covalent Allosteric Inhibitors of Glutaminase with Strong
    Hou W; Chen Z; Pan C; Ni M; Ruan H; Song J; Lu S; Bhasin A; Ruan BH
    ACS Med Chem Lett; 2023 Jul; 14(7):920-928. PubMed ID: 37465295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing the affinity of novel GLS1 allosteric inhibitors by targeting key residue Lys320.
    Zhu L; Chang X; Zhang S; Bai X; Finko AV; Xu X; Bian J; Liu X; Huang H
    Future Med Chem; 2023 Aug; 15(15):1393-1414. PubMed ID: 37610850
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel 1,3,4-Selenadiazole-Containing Kidney-Type Glutaminase Inhibitors Showed Improved Cellular Uptake and Antitumor Activity.
    Chen Z; Li D; Xu N; Fang J; Yu Y; Hou W; Ruan H; Zhu P; Ma R; Lu S; Cao D; Wu R; Ni M; Zhang W; Su W; Ruan BH
    J Med Chem; 2019 Jan; 62(2):589-603. PubMed ID: 30543285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Characterization of a Fluorescent Probe for GLS1 and the Application for High-Throughput Screening of Allosteric Inhibitors.
    Xu X; Kuang Z; Han J; Meng Y; Li L; Luan H; Xu P; Wang J; Luo C; Ding H; Li Z; Bian J
    J Med Chem; 2019 Nov; 62(21):9642-9657. PubMed ID: 31603674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of a novel glutaminase inhibitor.
    Cederkvist H; Kolan SS; Wik JA; Sener Z; Skålhegg BS
    FEBS Open Bio; 2022 Jan; 12(1):163-174. PubMed ID: 34698439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of novel tellurodibenzoic acid compounds as kidney-type glutaminase (KGA) inhibitors.
    Hou W; Zhou Y; Rui J; Bai R; Bhasin AKK; Ruan BH
    Bioorg Med Chem Lett; 2019 Jul; 29(13):1673-1676. PubMed ID: 31076348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism.
    Thangavelu K; Pan CQ; Karlberg T; Balaji G; Uttamchandani M; Suresh V; Schüler H; Low BC; Sivaraman J
    Proc Natl Acad Sci U S A; 2012 May; 109(20):7705-10. PubMed ID: 22538822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel glutaminase 1 allosteric inhibitor with 4-piperidinamine linker and aromatic heterocycles.
    Xu X; Chang X; Huang J; Zhang D; Wang M; Jing T; Zhuang Y; Kou J; Qiu Z; Wang J; Li Z; Bian J
    Eur J Med Chem; 2022 Jun; 236():114337. PubMed ID: 35428013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLS1 is a protective factor in patients with ovarian clear cell carcinoma and its expression does not correlate with ARID1A-mutated tumors.
    Clemente V; Hoshino A; Shetty M; Nelson A; Erickson BK; Baker R; Rubin N; Khalifa M; Weroha SJ; Lou E; Bazzaro M
    Cancer Res Commun; 2022 Aug; 2(8):784-794. PubMed ID: 36082022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-Enabled Discovery of Novel Macrocyclic Inhibitors Targeting Glutaminase 1 Allosteric Binding Site.
    Xu X; Wang J; Wang M; Yuan X; Li L; Zhang C; Huang H; Jing T; Wang C; Tong C; Zhou L; Meng Y; Xu P; Kou J; Qiu Z; Li Z; Bian J
    J Med Chem; 2021 Apr; 64(8):4588-4611. PubMed ID: 33792311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomolecular Interaction Assays Identified Dual Inhibitors of Glutaminase and Glutamate Dehydrogenase That Disrupt Mitochondrial Function and Prevent Growth of Cancer Cells.
    Zhu M; Fang J; Zhang J; Zhang Z; Xie J; Yu Y; Ruan JJ; Chen Z; Hou W; Yang G; Su W; Ruan BH
    Anal Chem; 2017 Feb; 89(3):1689-1696. PubMed ID: 28208301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel Glutaminase allosteric inhibitors through drug repurposing and comparative MMGB/PBSA and molecular dynamics simulation.
    Yousaf R; Navid A; Azam SS
    Comput Biol Med; 2022 Jul; 146():105669. PubMed ID: 35654625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of novel glutaminase 1 allosteric inhibitors with an alkane chain tail group.
    Chang X; Wang M; Zhang D; Zhang Y; Wang J; Li Z; Bian J; Xu X
    Eur J Med Chem; 2023 Jan; 246():115014. PubMed ID: 36525694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-Assembled Micellar Glutaminase Allosteric Inhibitor for Effective Therapeutic Intervention.
    Fang J; Chen Z; Li J; Li D; Wang W; Ruan BH
    Int J Nanomedicine; 2022; 17():213-225. PubMed ID: 35058693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney-Type Glutaminase Inhibitor Hexylselen Selectively Kills Cancer Cells via a Three-Pronged Mechanism.
    Ruan JJ; Yu Y; Hou W; Chen Z; Fang J; Zhang J; Ni M; Li D; Lu S; Rui J; Wu R; Zhang W; Ruan BH
    ACS Pharmacol Transl Sci; 2019 Feb; 2(1):18-30. PubMed ID: 32219214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.
    Li B; Cao Y; Meng G; Qian L; Xu T; Yan C; Luo O; Wang S; Wei J; Ding Y; Yu D
    EBioMedicine; 2019 Jan; 39():239-254. PubMed ID: 30555042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting glutaminase 1 (GLS1) by small molecules for anticancer therapeutics.
    Chen Y; Tan L; Gao J; Lin C; Wu F; Li Y; Zhang J
    Eur J Med Chem; 2023 Apr; 252():115306. PubMed ID: 36996714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, structure-activity relationship studies, and evaluation of novel GLS1 inhibitors.
    Jo M; Koizumi K; Suzuki M; Kanayama D; Watanabe Y; Gouda H; Mori H; Mizuguchi M; Obita T; Nabeshima Y; Toyooka N; Okada T
    Bioorg Med Chem Lett; 2023 May; 87():129266. PubMed ID: 37011768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ebselen: Mechanisms of Glutamate Dehydrogenase and Glutaminase Enzyme Inhibition.
    Yu Y; Jin Y; Zhou J; Ruan H; Zhao H; Lu S; Zhang Y; Li D; Ji X; Ruan BH
    ACS Chem Biol; 2017 Dec; 12(12):3003-3011. PubMed ID: 29072450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.